Table 2.
Univariate and multivariable Cox proportional hazards regression: risk of mortality (46 full dose aspirin users vs. 46 matched subjects)
| Characteristics | Univariate P | Multivariate P | HR (95% CI) |
|---|---|---|---|
| Full dose aspirin usage | 0.027* | 0.018* | 0.498 (0.280-0.888) |
| Age (≤ 65 y/> 65 y) | 0.917 | 0.245 | 1.419 (0.787-2.559) |
| Gender (male/female) | 0.464 | 0.084 | 0.545 (0.274-1.084) |
| Underlying liver disease | |||
| TB (≤ 3 mg/> 3 mg) | 0.023* | 0.071 | 2.356 (0.930-5.974) |
| GGT (≤ 75 µL/> 75 µL) | 0.011* | 0.008* | 2.303 (1.249-4.246) |
| PLT (≤ 100 × 109/L)/> 100 × 109/L) | 0.156 | ||
| Anti-HBV treatment | 0.156 | ||
| Cirrhosis | 0.782 | ||
| Tumor characteristics at initial TACE | |||
| Tumor size (≤ 5 cm/> 5 cm) | 0.001* | 0.031* | 2.087 (1.070-4.068) |
| Tumor number (solitary/multiple) | 0.899 | 0.529 | 0.784 (0.367-1.674) |
| Vascular invasion (without/with) | 0.044* | 0.049* | 2.539 (1.003-6.426) |
| Combined treatment | |||
| Hepatic resection (with/without) | 0.183 | 0.191 | 0.543 (0.217-1.356) |
| RFA (with/without) | 0.089 | 0.881 | 0.953 (0.504-1.801) |
Abbreviations: TB, total bilirubin; GGT, gamma-glutamyl transferase; PLT, platelet; AFP, alpha-fetoprotein; RFA, radiofrequency ablation.
*
P < 0.05.